Author:
Gerber Brittany,Cowling Tara,Chen Guanmin,Yeung Michael,Duquette Pierre,Haddad Paola
Funder
Novartis Pharmaceuticals Canada Inc.
Novartis Pharmaceuticals Canada Inc
Canadian Institutes for Health Research
Biogen-Idec
Genzyme
Hoffmann-La Roche
Novartis
Teva Canada Innovation
MS Society of Canada
Subject
Neurology (clinical),Neurology,General Medicine
Reference48 articles.
1. The Way Forward: Alberta’s Multiple Sclerosis Partnership;Alberta Health,2013
2. Adherence to first-line disease-modifying therapy for multiple sclerosis in kuwait;Alroughani;Int. J. MS Care,2012
3. Comparative effectiveness of fingolimod versus interferons or glatiramer acetate for relapse rates in multiple sclerosis: a retrospective US claims database analysis;Bergvall;Curr. Med. Res. Opin.,2013
4. Therapeutic Review: Recommendations for Drug Therapies for Relapsing-Remitting Multiple Sclerosis;CADTH,2013
5. Canadian Institute for Health Information (CIHI), 2014. Multiple Sclerosis.
Cited by
28 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献